Medtronic Aims To Bring Affordable/Portable HD To India By 2016
Espicom View: Chronic renal disease is become an increasing cause of morbidity in India, but the Indian Renal Foundation believes that healthcare expenditure in the country is not keeping pace. India has little in the way of infrastructure for renal care, and the cost of haemodialysis is currently unaffordable for the average citizen, estimated at around INR12,000-INR15,000 per month. Allowing patients to access haemodialysis in an affordable manner will be key in tackling rising cases.
Apollo Hospitals Enterprise and Medtronic have entered into a collaboration to bring to market an affordable and portable haemodialysis (HD) system in India to help improve access to care for end-stage renal disease (ESRD) patients who need renal replacement therapy (RRT).
This collaboration will use a Medtronic-developed technology platform, supported by clinical insight from Apollo. Both organisations envision an affordable and accessible healthcare delivery system that addresses the critical need for dialysis solutions in India. Both companies do not expect the collaboration to materially impact their earnings in the respective company's fiscal year.
Specifically, the collaboration seeks improved accessibility, outcomes, affordability, operational ease and environmental protection, while providing HD services to ESRD patients requiring RRT. Medtronic intends to develop and manufacture key components of this system in India, with an investment of more than INR1.5bn (US$25mn). For the first time, Medtronic is establishing an India R&D team that will focus on design, development and manufacturing of key components of the system in India. The commercial launch of the product is slated for 2016.
Omar Ishrak, Chairman and CEO of Medtronic, stated that the company's goal is to build a unique, internally developed system that will be portable, lower costs and be more efficient in its use of water and other critical features than existing dialysis systems. Apollo Hospitals and Medtronic expect that a new portable system would broaden a healthcare provider's capability to serve patients from hospital to home, saving costs to the healthcare system overall.